APA (7th ed.) Citation

T, Z., P, Z., & HX, L. (2021). CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press.

Chicago Style (17th ed.) Citation

T, Zhang, Zhang P, and Li HX. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.

MLA (8th ed.) Citation

T, Zhang, et al. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.